David Peereboom
Professor, Department of Medicine, School of Medicine · Case Western Reserve University
Credentials: · · · ·
History
Research
Chemotherapy delivery issues in central nervous system malignancy: a reality check
Review · Journal of Clinical Oncology · 2007 · 345 citations
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine · 2023 · 266 citations
Clinical Cancer Research · 2019 · 237 citations
50 papers · 6 as a fellow
37 papers
34 papers
32 papers
29 papers
- MV
25 papers
23 papers · 2 as a fellow
Alireza Mohammadi
17 papers
Clinical trials
- 2026–2028
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Principal investigator · Recruiting · Phase 2
Case Comprehensive Cancer Center
- 2023–2026
Methimazole in Patients With Progressive Glioblastoma
Principal investigator · Suspended · Phase 2
Case Comprehensive Cancer Center
- 2020–2022
Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
Principal investigator · Completed · Phase 2
David Peereboom
- 2019–2024
Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
Principal investigator · Completed · Phase 2
Case Comprehensive Cancer Center